Condition
Kidney, Polycystic, Autosomal Dominant
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00571909Not ApplicableCompletedPrimary
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
NCT00784030Not ApplicableCompletedPrimary
High Water Intake to Slow Progression of Polycystic Kidney Disease
NCT00890279Phase 2UnknownPrimary
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
NCT00541853Phase 4UnknownPrimary
CCB Safety Study in Treatment of Hypertension of ADPKD
Showing all 4 trials